110. Frexalimab Reduces Plasma Neurofilament Light Chain in Relapsing Multiple Sclerosis: Week 48 Data from a Phase 2 Trial
| Autor: | Kuhle, J. 1, Vermersch, P. 2, Djukic, B. 3, Geertsen, S. 3, Shafer, A. 3, Truffinet, P. 4, Giovannoni, G. 5 |
|---|---|
| Zdroj: | In Multiple Sclerosis and Related Disorders December 2024 92 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect